ETFs
T
TOVX
THERIVA BIOLOGICS INC
0.2572
+0.0049+1.94%After Hours: 0.4018 +0.1446 +56.22%19:59 04/17 EDT
OPEN/PREV CLOSE0.2564/0.2523
TODAY RANGE0.2475-0.2588
VOL111.84M
MARKET CAP11.80M
52 WEEK RANGE0.1628-1.500
AVG VOL (3M)14.12M
% TURNOVER243.71%
TURNOVER--
P/E (TTM)-0.1237
% RANGE4.40%
EPS(TTM)-2.0797
P/E(FORWARD)-1.1691
P/B0.5968
BVPS0.4310
DIVIDEND--
P/S--
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP11.61M
SHARES OUTSTANDING45.89M
NEXT EARNINGS05/12-05/18
FREE FLOAT45.14M
LOT SIZE1
EX-DATE08/26/2024
News
Press Releases
Financial Reports
Profile
TipRanks·04/09 20:52
Theriva Biologics Faces Delays in Warrant Approval Meeting
Benzinga·04/09 17:05
12 Health Care Stocks Moving In Thursday's Intraday Session
Dow Jones·03/31 21:07
Theriva Biologics Raised to Buy From Hold by Maxim Group
Dow Jones·03/31 21:07
Theriva Biologics Price Target Announced at $1.00/Share by Maxim Group
Benzinga·03/31 20:57
Maxim Group Upgrades Theriva Biologics to Buy, Announces $1 Price Target
TipRanks·03/31 13:48
Theriva Biologics upgraded to Buy at Maxim on clearer VCN-01 path
TipRanks·03/31 11:54
Theriva Biologics upgraded to Buy from Hold at Maxim
TipRanks·03/23 12:27
Theriva Biologics Advances VCN-01 Into Pivotal Phase 3
TipRanks·03/23 12:10
Theriva Biologics announces outcome of Type B End-of-Phase 2 meeting with FDA
Same Industry
Name/Symbol
Change%
Price